anmelden
OMX Stockholm 30
3.178,64
PKT
+17,35
PKT
+0,55
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.01.26 | Nordea Bank Abp Registered Buy | Deutsche Bank AG | |
| 14.01.26 | Volvo (B) Buy | UBS AG | |
| 14.01.26 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 13.01.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 13.01.26 | Volvo (B) Outperform | RBC Capital Markets | |
| 13.01.26 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 13.01.26 | Nordea Bank Abp Registered Underweight | Barclays Capital | |
| 12.01.26 | Hennes Mauritz (H M, H&M) Underperform | Bernstein Research | |
| 08.01.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 07.01.26 | Volvo (B) Market-Perform | Bernstein Research | |
| 07.01.26 | AstraZeneca Overweight | Barclays Capital | |
| 07.01.26 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 06.01.26 | ABB (Asea Brown Boveri) Underweight | Barclays Capital | |
| 06.01.26 | Hennes Mauritz (H M, H&M) Underperform | Bernstein Research | |
| 06.01.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.01.26 | Nordea Bank Abp Registered Buy | UBS AG | |
| 05.01.26 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 05.01.26 | Ericsson (Telefon L.M.Ericsson) (B) Underperform | Bernstein Research | |
| 18.12.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 17.12.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 16.12.25 | Volvo (B) Buy | UBS AG | |
| 16.12.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 12.12.25 | Hennes Mauritz (H M, H&M) Underperform | Bernstein Research | |
| 11.12.25 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 09.12.25 | Volvo (B) Hold | Deutsche Bank AG | |
| 08.12.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.12.25 | AstraZeneca Outperform | Bernstein Research | |
| 04.12.25 | Nordea Bank Abp Registered Neutral | Goldman Sachs Group Inc. | |
| 04.12.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.12.25 | Volvo (B) Outperform | RBC Capital Markets | |
| 01.12.25 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 26.11.25 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 26.11.25 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 25.11.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 25.11.25 | Nordea Bank Abp Registered Underweight | Barclays Capital | |
| 24.11.25 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 24.11.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 24.11.25 | Hennes Mauritz (H M, H&M) Equal Weight | Barclays Capital | |
| 21.11.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.